Evaluating Cost-Effectiveness of Accelerated Versus Standard Initiation of Renal Replacement Therapy in Severe Acute Kidney Injury
Highlight
– Study evaluates cost-utility of accelerated vs. standard KRT initiation in critically ill patients with severe AKI.
– Standard initiation increases quality-adjusted life years (QALYs) but at higher costs.
– Incremental cost-effectiveness ratio (ICER) for standard initiation is $23,208 per QALY gained, under commonly accepted thresholds.
– Economic findings are sensitive to postdischarge costs and regional variations in KRT dependence.
Study Background and Disease Burden
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.